))
Dr. Stephanie Waggel Explains the First Oral Drugs Approved for Postpartum Depression
Manage episode 376058197 series 3410734
Content provided by Kelly Hof. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Kelly Hof or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today, we invite you to join an enlightening discourse with our esteemed guest, Dr. Stephanie Waggel. We discuss the groundbreaking science behind the new medications approved to treat postpartum depression, which are sparking new hope for postpartum depression patients. Dr. Waggel adeptly unravels the science behind these drugs, making complex medical terms digestible and fascinating.
In our dialogue, we also step into the realm of controversies and implications of these FDA-approved drugs. We question the potential effects on breastfeeding mothers and scrutinize the role of pharmaceutical companies in these developments. We hope to enrich your understanding of postpartum depression and its promising new treatments. Join us for this profound conversation; let's embark on this knowledge journey together.
To connect with Dr. Waggel, go to
improvelifepllc.com
Coaching offer
Connect with Kelly Hof at kellyhof.com
Medical Disclaimer:
This podcast is intended as a safe space for women to share their birth experiences. It is not intended to provide medical advice. Each woman’s medical course of action is individual and may not appropriately transfer to another similar situation. Please speak to your medical provider before making any medical decisions. Additionally, it is important to keep in mind that evidence based practice evolves as our knowledge of science improves. To the best of my ability I will attempt to present the most current ACOG and AWHONN recommendations at the time the podcast is recorded, but that may not necessarily reflect the best practices at the time the podcast is heard. Additionally, guests sharing their stories have the right to autonomy in their medical decisions, and may share their choice to go against current practice recommendations. I intend to hold space for people to share their decisions. I will attempt to share the current recommendations so that my audience is informed, but it is up to each individual to choose what is best for them.
Chapters
1. New FDA-Approved Drug for Postpartum Depression (00:00:00)
2. Medication Controversies and Considerations (00:15:40)
3. Discussing Medical Topics and Mispronunciations (00:27:17)
88 episodes
Share
